Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354601
Status:
TERMINATED
Last Update Posted:
2017-08-30
First Post:
2006-07-19
Brief Title:
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer Fallopian Tube Cancer or Peritoneal Cavity Cancer
Sponsor:
Wake Forest University Health Sciences
Organization:
Wake Forest University Health Sciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Peritoneal Cavity Cancer |
| Fallopian Tube Cancer |
| Ovarian Cancer |
Keywords:
| Name | View |
|---|---|
| ovarian undifferentiated adenocarcinoma | View |
| fallopian tube cancer | View |
| peritoneal cavity cancer | View |
| recurrent ovarian epithelial cancer | View |
| ovarian clear cell cystadenocarcinoma | View |
| ovarian endometrioid adenocarcinoma | View |
| ovarian mucinous cystadenocarcinoma | View |
| ovarian serous cystadenocarcinoma | View |